Cargando…
ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
Screening for anaplastic lymphoma kinase (ALK) rearrangements is a very important process in treatment decision making for advanced non-small-cell lung cancer (NSCLC). Although fluorescent in situ hybridization (FISH) is considered the universally accepted reference standard, it is associated with t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147206/ https://www.ncbi.nlm.nih.gov/pubmed/30271189 http://dx.doi.org/10.2147/PGPM.S156672 |